Quantres Asset Management’s Biogen BIIB Stock Holding History

Quantres Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$638K	Sell	2,700 -1,400	-34%	-$441K	0.46%	71
2018 Q4	$1.23M	Sell	4,100 -500	-11%	-$160K	0.76%	31
2018 Q3	$1.63M	Buy	+4,600	New	+$1.58M	0.97%	23
2018 Q2	–	Sell	-900	Closed	-$246K	–	194
2018 Q1	$246K	Sell	900 -2,500	-74%	-$776K	0.15%	129
2017 Q4	$1.08M	Buy	3,400 +1,400	+70%	+$449K	0.68%	45
2017 Q3	$626K	Sell	2,000 -2,000	-50%	-$592K	0.4%	90
2017 Q2	$1.08M	Buy	+4,000	New	+$1.06M	0.71%	47
2016 Q4	–	Sell	-6,000	Closed	-$1.88M	–	162
2016 Q3	$1.88M	Sell	6,000 -4,400	-42%	-$1.3M	1.16%	21
2016 Q2	$2.52M	Buy	+10,400	New	+$2.74M	1.56%	13
2015 Q2	–	Sell	-14,500	Closed	-$6.12M	–	164
2015 Q1	$6.12M	Buy	+14,500	New	+$5.71M	6.11%	2
2014 Q3	–	Sell	-4,100	Closed	-$1.29M	–	160
2014 Q2	$1.29M	Buy	+4,100	New	+$1.23M	1.43%	18

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantres Asset Management's BIIB Position: Q1 2019 in Review

Quantres Asset Management reduced its Biogen (BIIB) stake by 34% in Q1 2019, selling an estimated $441K and leaving 2,700 shares worth $638K. The position accounts for 0.46% of the portfolio, ranked #71.

Quantres Asset Management first reported a position in BIIB in Q2 2014 and has held it in 11 quarters since. The position peaked at $6.12M in Q1 2015. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Quantres Asset Management held 2,700 shares of Biogen worth $638K as of Q1 2019.
Quantres Asset Management sold 1,400 Biogen shares in Q1 2019, an estimated $441K.
Biogen made up 0.46% of Quantres Asset Management's portfolio in Q1 2019, its #71 holding.
Quantres Asset Management first reported a position in Biogen in Q2 2014 and has held it in 11 quarters since.
Quantres Asset Management's Biogen position peaked at $6.12M in Q1 2015.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Quantres Asset Management's 13F filing for Q1 2019, filed 12 Apr 2019.